# 2025-19650: USPTO Demands Neat DNA Patents: Sequence Up!

2025-19650, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures, is a Federal Register notice from Commerce Department, Patent and Trademark Office published 2025-10-24, effective Comments regarding this information collection must be submitted on or before November 24, 2025.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19650
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19650
- Title: Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Type: Notice
- Agencies: Commerce Department; Patent and Trademark Office
- Citation: 90 FR 48553
- Published: 2025-10-24
- Effective: Comments regarding this information collection must be submitted on or before November 24, 2025.
- Comments close: 2025-11-24
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

USPTO Demands Neat DNA Patents: Sequence Up!

## Summary

The USPTO is asking for feedback on how it collects info from patent applications that include DNA or protein sequences. This review aims to keep the process smooth and reduce paperwork for inventors and companies. If you’re involved in biotech patents, now’s the time to share your thoughts before November 24, 2025!

## Abstract

The United States Patent and Trademark Office (USPTO) will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. The USPTO invites comments on this information collection renewal of 0651-0024 (Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures), which helps the USPTO assess the impact of its information collection requirements and minimize the public's reporting burden. Public comments were previously requested via the Federal Register on June 26, 2025, during a 60-day comment period (90 FR 27284). This notice allows for an additional 30 days for public comment.

## Effects PRIA read

- Sequence Listings Required in Patent Filings: cost, low. If your patent application discloses DNA (nucleotide) or protein (amino acid) sequences, you must include a separate sequence listing part with the application under the rules set out in 37 CFR 1.831 (for applications filed on or after July 1, 2022) or 37 CFR 1.821(a) (for applications filed on or…
- Paperwork Time and Cost Estimate: cost, low. The USPTO estimates this information collection will have about 30,000 annual respondents and 30,000 annual responses, with each response taking about 6 hours to complete. The notice estimates a total annual respondent burden of 180,000 hours and an estimated total annual non-hourly cost burden of…
- CRF Submission for Older Application Amendments: cost, low. For sequence listings filed as 37 CFR 1.825 amendments in applications with a filing date on or before June 30, 2022, the submission may also require a new or substitute computer readable form (CRF) copy of the sequence listing under 37 CFR 1.821(e) and 1.824, incorporated as part of the amendment…

## Related documents

- [2026-22924](https://policyrisk.com/federal-register/2026-22924): Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Respo…, 2026-11-10
- [2026-22798](https://policyrisk.com/federal-register/2026-22798): Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Inter…, 2026-11-09
- [2026-22193](https://policyrisk.com/federal-register/2026-22193): Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; DOCX…, 2026-10-30
- [2026-19613](https://policyrisk.com/federal-register/2026-19613): Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Trade…, 2026-09-25
- [2026-19576](https://policyrisk.com/federal-register/2026-19576): Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Gener…, 2026-09-24
- [2026-17524](https://policyrisk.com/federal-register/2026-17524): Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Paten…, 2026-08-27

## Sources
- [2025-19650 on federalregister.gov](https://www.federalregister.gov/documents/2025/10/24/2025-19650/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-for)
- [2025-19650 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-10-24/pdf/2025-19650.pdf)

## Related
- [Previous: 2025-19649, Corporate Senior Executive Management Office Notice of Performance Review Board…](https://policyrisk.com/federal-register/2025-19649)
- [Next: 2025-19651, Annual Pay Ranges for Physicians, Dentists, Podiatrists, and Optometrists of th…](https://policyrisk.com/federal-register/2025-19651)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19650 (as of 2026-06-08).
